Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-07-02
1998-11-10
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514255, 514269, 514275, 514256, 514350, 514352, 514354, 514355, 514356, 514438, 514445, 514447, 514461, 514471, 514474, 514535, 514543, 514544, 514617, 514618, 514622, 514619, 514620, 514361, 514365, 514369, 514370, 514374, 514376, 514398, 514399, 514400, 514407, 514403, 562490, 562452, 562433, 562473, 562495, 560 8, 560 17, 560 19, 560 43, 560104, 560435, 560183, 564162, 564164, 564182, 564184, 544406, 544407, 544335, 544318, 544319, 544329, 544332, 544224, 544238, 544239, 546299, 546309, 546310, 546315,
Patent
active
058344683
ABSTRACT:
heteroaryl-) alkyl-, alkyloxy-, alkylthio-, oxo-, thio-, and alkylamino!- heteroaryl and aryl!- alkylamino-, aminoalkyl-, alkyloxy-, and alkylthio!- aryl and heteroaryl compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof, which are useful as antagonists of the pain enhancing effects of E-type prostaglandins, to processes for the preparation of such compounds, to pharmaceutical compositions comprising such compounds, and to methods for treating pain comprising the administration of such compounds.
REFERENCES:
patent: 3632760 (1972-01-01), Shen et al.
patent: 3657430 (1972-04-01), Shen et al.
patent: 4152452 (1979-05-01), Douglas et al.
patent: 4277496 (1981-07-01), Los
patent: 4350822 (1982-09-01), Albright et al.
patent: 4937373 (1990-06-01), Carson et al.
patent: 5087743 (1992-02-01), Janssen et al.
patent: 5105017 (1992-04-01), Dillard
patent: 5189033 (1993-02-01), Tucker
patent: 5317101 (1994-05-01), Oldfield et al.
patent: 5324743 (1994-06-01), Dillard et al.
patent: 5393768 (1995-02-01), Dillard
patent: 5409930 (1995-04-01), Spada et al.
patent: 5420270 (1995-05-01), Chandrakumar et al.
patent: 5441950 (1995-08-01), Collins et al.
patent: 5480883 (1996-01-01), Spada et al.
patent: 5530157 (1996-06-01), Mewshaw et al.
Brown et al., J. Med. Chem. 1989, 32, 807-826.
Derwent Patent Abstract of DE 1,543,519 (Abstract No. 71-26731S).
Derwent Patent Abstract of DE 2,701,854 (Abstract No. 52629Y/30).
Albright et al., J. Med. Chem. 1983, 26, 1378-1393.
Derwent Patent Abstract of WO 93/23364 (Abstract No. 93-386430/48).
Ames et al., J.C.S. Perkins Transaction 1, (1975) (14) 1390-1395.
Breault Gloria Anne
Oldfield John
Tucker Howard
Warner Peter
Darkes Paul R.
Grumbling Matthew V.
Zeneca Limited
LandOfFree
Substituted aryl and heteroaryl compounds as E-type prostaglandi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted aryl and heteroaryl compounds as E-type prostaglandi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted aryl and heteroaryl compounds as E-type prostaglandi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516982